Call us at +1 (619) 493 9457 WhatsApp +52 (663) 215 5668

GLP-1 Weight
Management Treatment

Semaglutide and Tirzepatide
With Medical Supervision and Monthly Treatment Plans

Why Are Our Treatments Different?

Each consultation is personalized. Our medical team will review your medical history and explain the options that may be appropriate for you.

Medical Supervision

Ongoing care provided by healthcare professionals throughout your treatment.

Monthly Consultations

Regular follow-ups to adjust your plan and safely optimize your results.

Nutrition Plan

Professional nutritional guidance designed to complement your medical treatment.

U.S. Shipping

Secure delivery directly to your home anywhere in the United States.

Semaglutide

Price range: $150.00 through $250.00

Tirzepatide

Price range: $250.00 through $500.00

Research Only

Retatrutida

Price range: $275.00 through $575.00

Product total
Options total
Grand total
The medication comes in syringes of 30 or 50 units. *THEY ARE NOT DOSING PENS.* One injection should be administered per week for at least 4 weeks, maintaining the same dose.
SEMAGLUTIDE
PROMOTION
LIMITED-TIME
0.25 mg
$150 USD
$135 USD
  • 4 injections
0.50 mg
$150 USD
$135 USD
  • 4 injections
0.75 mg
$150 USD
$135 USD
  • 4 injections
1 mg
$200 USD
$180 USD
  • 4 injections
1.5 mg
$200 USD
$180 USD
  • 4 injections
2 mg
$250 USD
$225 USD
  • 4 injections
2.5 mg
$250 USD
$225 USD
  • 4 injections
TIRZEPATIDE
PROMOTION
LIMITED-TIME
2.5 mg
$250 USD
$225 USD
  • 4 injections
5 mg
$300 USD
$270 USD
  • 4 injections
7.5 mg
$350 USD
$315 USD
  • 4 injections
10 mg
$400 USD
$360 USD
  • 4 injections
12.5 mg
$450 USD
$405 USD
  • 4 injections
15 mg
$500 USD
$450 USD
  • 4 injections
RETATRUTIDE
Research Only
1.5 mg
$275 USD
$247.5 USD
  • 4 injections
3 mg
$350 USD
$315 USD
  • 4 injections
6 mg
$425 USD
$382.5 USD
  • 4 injections
9 mg
$500 USD
$450 USD
  • 4 injections
12 mg
$575 USD
$517.5 USD
  • 4 injections

Your purchase includes the medication at the selected dosage, detailed usage instructions, general recommendations, specialized nutrition guidance for patients enrolled in our program, and ongoing support from our medical team throughout your treatment.

Most adults with overweight or obesity may benefit from GLP-1 treatment; however, it is not appropriate for everyone.

In general, this treatment is not recommended for patients who:

  • Have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • Have active or recurrent pancreatitis.

  • Have severe gastrointestinal disorders that affect gastric emptying.

  • Have advanced or uncontrolled diabetic retinopathy.

  • Are pregnant, breastfeeding, or planning to become pregnant.

  • Have a known allergy to any of the medication’s components.

Our approach is designed for patients seeking responsible and informed weight management, always prioritizing safety, clear medical guidance, and overall well-being.

The medication is administered as a subcutaneous injection once per week. We provide clear, step-by-step instructions, and our team is available to guide you if you have any questions about the administration process.

GLP-1 treatment is not recommended during pregnancy or while breastfeeding. If you are currently pregnant, nursing, or planning to become pregnant, please consult with our medical team before making a purchase.

We offer standard shipping (5–7 business days) and express shipping (1–2 business days). The treatment is shipped in secure packaging and includes detailed instructions.

Yes — in fact, it can enhance your overall results. We provide basic nutritional guidance to help support your treatment.

Treatment Presentation
The peptide is provided in 25-unit syringes. These are not pre-filled dosing pens.
A once-weekly administration is recommended for at least 4 weeks, maintaining the same dosage, always under medical supervision.

Semaglutide (GLP-1)

Medical Treatment for Weight Management

  • A widely studied treatment used as medical support for appetite control and metabolic regulation.
  • In clinical studies, many patients have experienced progressive weight reduction as part of a comprehensive weight management program.
  • Helps promote a greater feeling of fullness, which may support sustainable changes in eating habits.
  • Administered as a once-weekly injection, making it a practical and convenient option to incorporate into your routine.
  • Its dosing schedule helps maintain stable medication levels in the body, supporting a consistent response over time.
Treatment Presentation
The peptide is provided in 25-unit syringes. These are not pre-filled dosing pens.
A once-weekly administration is recommended for at least 4 weeks, maintaining the same dosage, always under medical supervision.

Tirzepatide (GLP-1)

Medical Treatment for Weight Management

  • A next-generation therapy designed to act on two key metabolic pathways (GLP-1 and GIP), allowing for a more comprehensive approach to appetite control and metabolic regulation.
  • In clinical studies, patients have demonstrated more significant and sustained weight reduction, especially when incorporated into a structured and medically supervised program.
  • Enhances the feeling of fullness, helping reduce caloric intake and supporting long-term adherence to healthy lifestyle changes.
  • Administered as a once-weekly injection, offering convenience and consistency without interfering with daily routines.
  • Its dosing structure supports a more robust and stable metabolic response, making it a preferred option for patients seeking more noticeable and progressive results.
Treatment Presentation
The peptide is provided in 25-unit syringes. These are not pre-filled dosing pens.
A once-weekly administration is recommended for at least 4 weeks, maintaining the same dosage, always under medical supervision.

Retatrutide (GLP-1)

Medical Treatment for Weight Management (Research only)

  • A next-generation triple agonist therapy (GLP-1, GIP, and glucagon), designed to target multiple metabolic pathways for enhanced weight loss and metabolic regulation.
  • In clinical studies, patients have shown significant and accelerated weight reduction, with promising results in fat loss and energy expenditure.
  • Helps regulate appetite while simultaneously increasing calorie burning, offering a dual-action approach to weight management.
  • May improve metabolic flexibility, supporting better glucose control and overall metabolic health.
  • Administered as a once-weekly injection, providing convenience and consistency within a structured treatment plan.
  • Its advanced mechanism supports more pronounced and progressive results, making it a cutting-edge option for patients seeking next-level weight management solutions.
Logo_White
Dr. Luis Pasten © 2026 | Overweight Reduction Center | All rights reserved.
Call Now Button